Skip to content
LinusBio Wins 2024 BioTech Breakthrough Award for “Overall MedTech Company of the Year”
Novozymes and LinusBio announce collaboration to accelerate scientific discovery in Biohealth
LinusBio Recognized at the 2022 Mount Sinai Innovation Awards
WATCH: Detecting Autism at Birth and Opportunity for Early Intervention
Linus Biotechnology Inc. Receives FDA Breakthrough Device Designation for StrandDx™-ASD Exposome Sequencing Diagnostic
Mount Sinai Spin-Off Linus Biotechnology Inc. to Revolutionize Precision Medicine with Exposome Sequencing